BIOCORP Inactive Instrument
Biocorp Stock
Equities
ALCOR
FR0012788065
Advanced Medical Equipment & Technology
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
More news
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Eric Dessertenne
CEO | Chief Executive Officer | - | 14-05-31 |
| Director of Finance/CFO | - | - | |
Sylvaine Dessard
IRO | Public Communications Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 15-05-11 | |
Emilie Gardette
BRD | Director/Board Member | - | 15-05-11 |
Julien Gardette
BRD | Director/Board Member | - | 15-05-11 |
Biocorp specializes in the development and manufacture of medical devices and drug delivery systems. The company offers traditional delivery systems, connected injection systems and monitoring devices.
Net sales break down by source of income between sales of services (86.9%) and products (13.1%).
At the end of 2022, Biocorp has a production site located in France.
France accounts for 62.6% of net sales.
Calendar
2024-09-25
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +8.88% | 219B | |
| +8.68% | 185B | |
| +14.25% | 135B | |
| +28.18% | 107B | |
| +14.65% | 51.28B | |
| +4.48% | 51.01B | |
| +4.39% | 41.85B | |
| +7.00% | 37.02B | |
| +26.06% | 31.27B |
